A new Arizona law could permanently expand statewide use of virtual and telephonic doctors' visits, which became more commonplace during the COVID-19 pandemic. "It catapults Arizona to the front of the line in terms of telehealth law nationally," said Dr. Ronald Weinstein, founding director of the Arizona Telemedicine Program at the University of Arizona and a president emeritus of the American Telemedicine Association. "It's huge."

Dr. Ken Batai,has documented an increased risk of mortality among Arizona’s Hispanic American and Native American kidney cancer patients.

U.S. officials are poised to authorize the Pfizer COVID-19 vaccine for children 12 to 15 years old, while some countries still struggle to vaccinate health care workers risking their lives daily. The situation presents a moral dilemma over “vaccine nationalism” — a principle rooted in the idea that a country should vaccinate its own population before moving on to other populations, says David Beyda, MD, chair of the Department of Bioethics and Medical Humanism at the College of Medicine in Phoenix. “Giving it to kids is going to move us toward herd immunity. From an ethical perspective, the primary concern is getting as many people vaccinated here as possible,” he says.

A new UArizona Health Sciences program will prepare students to work in the field of gerontology, where demand for specialized professionals is high.

A new study found people may benefit from taking blood pressure medication even if they don’t have hypertension. Dr. Joseph Alpert, a professor of medicine and a cardiologist at the College of Medicine – Tucson and Sarver Heart Center, said some people with mildly elevated blood pressure levels are given blood pressure-lowering medications. “Studies show that they have lower risk for stroke, for example, if we get their BP down to the new lower levels of BP,” Alpert said.

Mobile applications can’t replace doctors, but they can be useful tools if you want to take a proactive approach to skin care.

Data from the CDC has found that five million people in the U.S., roughly 8% of those who received a first dose, have missed their second shot of the COVID-19 vaccine. Yet many scientists see a glimmer of hope: 8% missed means 92% returned, which is surprisingly high. "I see that as a really amazing win," said Saskia Popescu, an infection prevention epidemiologist at the Mel and Enid Zuckerman College of Public Health. "There's not enough credit that goes into acknowledging how national vaccination in the middle of a pandemic is a Herculean effort."

A new mobile health unit program is getting more vaccines in the arms of rural, Hispanic and other hard-to-reach populations in southern Arizona.